Concentrix Corporation
CNXC
$39.60
-$0.71-1.76%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.72B | 9.63B | 9.59B | 9.62B | 9.40B |
| Total Other Revenue | -- | 575.94M | 1.17B | 1.76B | 2.28B |
| Total Revenue | 9.72B | 9.63B | 9.59B | 9.62B | 9.40B |
| Cost of Revenue | 6.29B | 6.19B | 6.14B | 6.17B | 6.00B |
| Gross Profit | 3.43B | 3.44B | 3.45B | 3.45B | 3.40B |
| SG&A Expenses | 2.03B | 2.01B | 2.00B | 2.01B | 2.19B |
| Depreciation & Amortization | 679.86M | 684.64M | 691.45M | 691.45M | 447.36M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.01B | 8.89B | 8.83B | 8.87B | 8.64B |
| Operating Income | 715.49M | 739.93M | 756.06M | 746.09M | 761.56M |
| Income Before Tax | 376.86M | 291.84M | 327.24M | 299.27M | 263.48M |
| Income Tax Expenses | 60.75M | 47.20M | 57.87M | 48.06M | 58.42M |
| Earnings from Continuing Operations | 316.11 | 244.63 | 269.37 | 251.22 | 205.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 316.11M | 244.63M | 269.37M | 251.22M | 205.05M |
| EBIT | 715.49M | 739.93M | 756.06M | 746.09M | 761.56M |
| EBITDA | 1.38B | 1.41B | 1.44B | 1.45B | 1.45B |
| EPS Basic | 4.74 | 3.65 | 4.00 | 3.72 | 3.09 |
| Normalized Basic EPS | 4.68 | 4.11 | 4.41 | 4.11 | 3.69 |
| EPS Diluted | 4.74 | 3.65 | 4.00 | 3.72 | 3.09 |
| Normalized Diluted EPS | 4.67 | 4.10 | 4.41 | 4.11 | 3.69 |
| Average Basic Shares Outstanding | 254.31M | 256.37M | 258.28M | 259.91M | 257.44M |
| Average Diluted Shares Outstanding | 254.53M | 256.57M | 258.50M | 260.23M | 257.83M |
| Dividend Per Share | 1.33 | 1.30 | 1.27 | 1.24 | 1.21 |
| Payout Ratio | 28.16% | 35.72% | 31.77% | 33.36% | 39.89% |